Relapsed or Cisplatin-Refractory Germ Cell Cancer
1 clinical trials · Condition
◉ Watch Relapsed or Cisplatin-Refractory Germ Cell Cancer
| Record | Firm | Date |
|---|---|---|
| Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer (NCT00371553) | British Columbia Cancer Agency | 2006-11-01 |
Track Relapsed or Cisplatin-Refractory Germ Cell Cancer automatically
Every clearance here is in the API, with alerts when new ones post.